Breakthrough in Vision: UNITY Biotechnology’s Promising Results for Eye Disease Treatment
UNITY Biotechnology is set to present promising results from their Phase 2b ASPIRE study on 24 March 2025, with potential breakthroughs in treating Diabetic Macular Oedema (DME). The innovative compound…